{
    "paper_id": "PMC7153358",
    "metadata": {
        "title": "Management of inflammatory bowel disease patients in the COVID-19 pandemic\nera: a Brazilian tertiary referral center guidance",
        "authors": [
            {
                "first": "Nat\u00e1lia",
                "middle": [
                    "Sousa",
                    "Freitas"
                ],
                "last": "Queiroz",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Lu\u00edsa",
                "middle": [
                    "Leite"
                ],
                "last": "Barros",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Matheus",
                "middle": [
                    "Freitas",
                    "Cardoso"
                ],
                "last": "de Azevedo",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jane",
                "middle": [],
                "last": "Oba",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Carlos",
                "middle": [
                    "Walter"
                ],
                "last": "Sobrado",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Alexandre",
                "middle": [],
                "last": "de Sousa Carlos",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Luciane",
                "middle": [
                    "Reis"
                ],
                "last": "Milani",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Aytan",
                "middle": [
                    "Miranda"
                ],
                "last": "Sipahi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Aderson",
                "middle": [
                    "Omar",
                    "Mour\u00e3o",
                    "Cintra"
                ],
                "last": "Dami\u00e3o",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "IBD treatment often involves the prescription of immunosuppressants and IBD patients are\nlikely to be more susceptible to infection, depending on the medications in use. As the\noutbreak became a rapidly spreading pandemic, several centers around the world have raised\nconcerns that immunocompromised patients may be at increased risk of developing SARS-CoV-2\ninfection or severe respiratory disease 13.",
            "cite_spans": [
                {
                    "start": 399,
                    "end": 401,
                    "mention": "13",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In general, IBD patients taking immunomodulators may be more susceptible to infection,\nespecially in combination with biologics, mainly anti-TNF agents. In addition,\nmalnutrition, comorbidities, older age, previous history of serious infections, and\nunderlying IBD activity may also be risk factors for infections 14,15.",
            "cite_spans": [
                {
                    "start": 314,
                    "end": 316,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 317,
                    "end": 319,
                    "mention": "15",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Previous studies have demonstrated that clinically active IBD and exposure to thiopurines\nincrease the risk of viral infections 16,17. However, unlike other viruses (Influenza, Herpes,\nCytomegalovirus, Adenovirus, Rhinovirus, Norovirus, and Respiratory Syncytial Virus),\ncoronaviruses have not been shown to cause more severe disease in immunosuppressed\npatients 13,15,17.",
            "cite_spans": [
                {
                    "start": 128,
                    "end": 130,
                    "mention": "16",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 131,
                    "end": 133,
                    "mention": "17",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 363,
                    "end": 365,
                    "mention": "13",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 366,
                    "end": 368,
                    "mention": "15",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 369,
                    "end": 371,
                    "mention": "17",
                    "ref_id": "BIBREF16"
                }
            ],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "So far, there is an international consensus that patients with IBD are not at greater\nrisk of infection with SARS-CoV-2 than the general population, although it is uncertain\nwhether active inflammation increases the risk of getting SARS-CoV-2. It is also uncertain\nif IBD patients infected with SARS-CoV-2 have a higher risk of developing COVID-19 or\nhigher rate of complications or mortality resulting from the disease, although data\nregarding immunosuppressed patients and SARS-CoV-2 infection are very scarce 14.",
            "cite_spans": [
                {
                    "start": 512,
                    "end": 514,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Guan et al. did not observe the use of immunomodulators as a risk factor for serious\ndiseases in 1,099 patients in China 18. As of April\n3, 2020, 12 deaths (9 male) were reported among the 275 patients with IBD and COVID-19 in\nthe international Surveillance Epidemiology of Coronavirus Under Research Exclusion\n(SECURE)-IBD database. Of those, three patients were younger than 65 years old, and all\nreceived treatment with more than one immunosuppressant (steroid+JAK inhibitor;\nadalimumab+methotrexate; adalimumab+azathioprine+steroid) 19. Nevertheless, these cases should be interpreted with caution since many\ncases with mild disease were not tested for COVID-19.",
            "cite_spans": [
                {
                    "start": 121,
                    "end": 123,
                    "mention": "18",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 537,
                    "end": 539,
                    "mention": "19",
                    "ref_id": "BIBREF18"
                }
            ],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In a coordinated initiative from the British Society of Gastroenterology (BSG) and\nCrohn's and Colitis UK association, specific guidance was provided for IBD patients\naccording to their risk depending on the medications in use, age, and other risk factors.\nThrough a decision tree, patients are stratified according to highest, moderate, or lowest\nrisk of serious complications from COVID-19. Patients at the highest risk are those who\neither have a comorbidity (respiratory, cardiac, hypertension, or diabetes mellitus),\nthose over 70 years old and on any immunosuppressant therapy for IBD, those of any age\nthat are receiving \u226520 mg prednisolone, new induction therapy with biologics and\nimmunomodulators (combination therapy) within 6 weeks, those with moderate to severe\nactive disease or short gut syndrome, and patients requiring parenteral nutrition.\nPatients receiving biological therapy, thiopurines, calcineurin inhibitors, JAK\ninhibitors, or combination therapy are stratified as at moderate risk and the remaining\nIBD patients as at the lowest risk. Patients at the highest risk are required to\nself-isolate, while patients at moderate or lowest risk should follow strict or general\npopulace social distancing, respectively 20.",
            "cite_spans": [
                {
                    "start": 1236,
                    "end": 1238,
                    "mention": "20",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In our center, we followed BSG recommendations regarding risk stratification, although we\nalso considered patients subjected to IBD surgical procedures within 30 days at highest\nrisk of serious complications of COVID-19. A brief summary of specific recommendations\nprovided by us to the patients according to their risk is described in Table 1.",
            "cite_spans": [],
            "section": "What is the risk of COVID-19 in the IBD population? ::: INTRODUCTION",
            "ref_spans": [
                {
                    "start": 336,
                    "end": 343,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "For the past month, emerging evidence has guided an optimized approach to prevent\ncoronavirus infection in IBD patients to assure the safety of ongoing treatment.",
            "cite_spans": [],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Similar to the general population, IBD patients were advised to stay at home, maintain\nproper distance while talking, wash hands with soap or alcohol-based sanitizer, and avoid\ntouching facial mucosa (Table 1).",
            "cite_spans": [],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": [
                {
                    "start": 201,
                    "end": 208,
                    "mention": "Table 1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Our institute, the largest in Latin America, has implemented a massive structural plan to\nevacuate wards, equip intensive care units, and to provide sufficient beds for patients\ndiagnosed with COVID-19 infection. These institutional rearrangements have challenged our\nIBD team and a specific approach to maintain IBD care during the pandemic was needed. A\nsummary of measures set to adapt IBD care is described in Table 2.",
            "cite_spans": [],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": [
                {
                    "start": 414,
                    "end": 421,
                    "mention": "Table 2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "In the gastroenterology department, hospitalized IBD patients were reallocated to an\nisolated building with specialized medical staff, which has minimized exposure to the\nvirus.",
            "cite_spans": [],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In our outpatient clinic, the great majority of appointments were rescheduled. Although a\nformal tele-health system was not available, medical staff closely monitored patients with\nsevere active disease that required corticosteroids or were being treated with combination\ntherapy via telephone calls. At this moment, laboratory tests are strictly limited, and\nthe endoscopy unit has only been attending to urgent cases, according to the\nrecommendations in the guidelines 11. Therefore,\nwhenever deemed necessary, ileocolonoscopy was replaced by fecal calprotectin.",
            "cite_spans": [
                {
                    "start": 471,
                    "end": 473,
                    "mention": "11",
                    "ref_id": "BIBREF10"
                }
            ],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "At our infusion center, the staff requested us to select patients that could have their\ninfusion postponed for 1 or 2 weeks in order to make more space available for the\nrearrangement of seats. We used patients in deep clinical and endoscopic remission at the\nlast outpatient clinic assessment as the main criteria for the rescheduling of infusions.\nIn the course of infusions, a distance of approximately 1.5 m between seats was considered\nsafe and no accompanying person was permitted. Although we acknowledged that the use of\nsurgical masks for immunodeficient patients is indicated, it was not always available.\nThus, a screening protocol with an objective interview was implemented prior to admission\nto systematically assess for acute respiratory tract symptoms, such as cough, dyspnea, or\nfever, among both IBD patients and their contacts. Asymptomatic patients received IV\ninfusions as planned, while those with highly suspicious coronavirus infection were\nreferred to the emergency room. In cases where initiation of biologics was extremely\nnecessary, and when it was feasible, preference for those biologics that could be offered\nsubcutaneously, at home, instead of intravenously, which would require an infusion center,\nwas recommended.",
            "cite_spans": [],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The association of malnourishment and the risk of infections is well described in IBD\nliterature 23,24. Hypoalbuminemia is considered a systemic inflammatory marker and is present\nin one-fifth of IBD patients 25,26. In the present context of the COVID-19 pandemic,\nsocial isolation could negatively impact the patient's access to healthy foods or dietary\nhabits resulting in ensuing nutritional deficits. Thus, we have recommended a balanced\ndiet with four to six small meals a day and adequate hydration. All patients were also\nencouraged to quit smoking.",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 99,
                    "mention": "23",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 100,
                    "end": 102,
                    "mention": "24",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 209,
                    "end": 211,
                    "mention": "25",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 212,
                    "end": 214,
                    "mention": "26",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In addition, IBD patients were advised to update general immunization schedules,\nparticularly the influenza vaccination, as routinely recommended by the European Crohn's\nand Colitis Organization (ECCO) guidelines 27,28.",
            "cite_spans": [
                {
                    "start": 213,
                    "end": 215,
                    "mention": "27",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 216,
                    "end": 218,
                    "mention": "28",
                    "ref_id": "BIBREF27"
                }
            ],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Several studies have examined the role of vitamin supplementation to control viral\nreplication 29. Despite the lack of randomized\ncontrolled trials in this scenario, we have kept our IBD patients on vitamin D and iron\nreplacement, if iron-deficiency anemia was detected.",
            "cite_spans": [
                {
                    "start": 95,
                    "end": 97,
                    "mention": "29",
                    "ref_id": "BIBREF28"
                }
            ],
            "section": "General recommendations and strategies to minimize exposure to the virus ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "At the present time, it does not seem appropriate to recommend discontinuing\nimmunosuppressant treatment in patients with IBD 11. There is a risk of reactivation of the disease for those patients who stop\ntheir treatment, and active inflammation is associated with an increased risk of\nhospitalization, surgery, infection, and exposure to steroids (which should be avoided in\nthe context of COVID-19) 20,30.",
            "cite_spans": [
                {
                    "start": 126,
                    "end": 128,
                    "mention": "11",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 401,
                    "end": 403,
                    "mention": "20",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 404,
                    "end": 406,
                    "mention": "30",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Management of IBD medications during the pandemic and potential COVID-19\ninfection ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The use of non-hormonal anti-inflammatory drugs should be contraindicated because of\ntheir association with adverse outcomes in other viral respiratory infections and their\npotential role as a trigger for the reactivation of IBD 14.",
            "cite_spans": [
                {
                    "start": 229,
                    "end": 231,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Management of IBD medications during the pandemic and potential COVID-19\ninfection ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "To date, there are no formal evidence-based recommendations from clinical societies or\ngovernments for immunosuppressed patients, like those with IBD. Table 3 summarizes the therapy-specific considerations for IBD patients\nbased mainly on expert opinions and must be interpreted in a patient-specific context.\nThese recommendations can be modified and updated as new evidence emerges 14,20.",
            "cite_spans": [
                {
                    "start": 384,
                    "end": 386,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 387,
                    "end": 389,
                    "mention": "20",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Management of IBD medications during the pandemic and potential COVID-19\ninfection ::: INTRODUCTION",
            "ref_spans": [
                {
                    "start": 151,
                    "end": 158,
                    "mention": "Table 3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "In general, a patient with moderate to severely active Crohn's disease or\nulcerative colitis should be treated with the same therapies that would be chosen,\nregardless of the COVID-19 pandemic 14.",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 195,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Management of IBD medications during the pandemic and potential COVID-19\ninfection ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In an asymptomatic IBD patient who has tested positive for SARS-CoV-2 and whose treatment\nhas been discontinued, IBD drugs can be restarted after 14 days (assuming they have not\ndeveloped COVID-19) 14.",
            "cite_spans": [
                {
                    "start": 198,
                    "end": 200,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Management of IBD medications during the pandemic and potential COVID-19\ninfection ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In cases of the occurrence of signs and symptoms suggestive of COVID-19, the patient must\nimmediately communicate with the healthcare team. In this context, it is recommended to\npause immunosuppressant therapy until the infection resolves. The therapy can be resumed\nafter complete resolution of the symptoms of COVID-19 or, ideally, after two negative PCR\ntests of the nasopharyngeal swab, collected with a more than 24-h interval between them\n(this strategy is not currently feasible in Brazil, where there is a shortage of tests for\ncoronavirus) 14,20.",
            "cite_spans": [
                {
                    "start": 549,
                    "end": 551,
                    "mention": "14",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 552,
                    "end": 554,
                    "mention": "20",
                    "ref_id": "BIBREF19"
                }
            ],
            "section": "Management of IBD medications during the pandemic and potential COVID-19\ninfection ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The novel coronavirus has created a new dilemma for surgeons worldwide. While many\npatients await surgery, the risks of developing severe pulmonary infection and prolonged\nhospitalization are concerning. This is particularly critical for IBD patients, who are\nimmunosuppressed by both the nature of the disease and commonly used medications, in\naddition to nutritional deficits. Surgical care in this context may add additional\nmorbidity.",
            "cite_spans": [],
            "section": "IBD surgery in the context of the COVID-19 pandemic ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The main goal at this moment is to ensure the safety of patients and health care workers.\nCurrent recommendations are based largely on experts' opinions and may change rapidly as\nthe outbreak is expected to escalate over the next weeks. A recent report from Wuhan,\nChina, describes the outcomes of 34 patients that underwent elective surgical procedures\nduring the COVID-19 incubation period in the early phase of the outbreak. All patients\ndeveloped COVID-19 pneumonia shortly after surgery, 15 (44.1%) patients required admission\nto the intensive care unit and seven patients (20.5%) died 31.",
            "cite_spans": [
                {
                    "start": 591,
                    "end": 593,
                    "mention": "31",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "IBD surgery in the context of the COVID-19 pandemic ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Therefore, it is highly recommended by most surgical societies around the world to\npostpone all elective surgeries and endoscopic procedures, aiming to protect patients and\nsurgeons and also to minimize the use of necessary resources, such as hospital beds and\npersonal protective equipment (PPE) 32,33. Regarding the surgical procedure, there is concern\nfor the aerosolization of the SARS-CoV-2 virus in minimally invasive procedures, although\nthere is no robust evidence. This could also be the case with electrocautery use during\nopen surgery. Strict use of PPE according to local practice is advisable, which includes\nan N95 mask and face shield protection. Negative pressure surgical rooms should be used if\navailable and for laparoscopic surgery, a smoke evacuation system is advisable.\nAdditionally, only essential staff should take part in the surgery.",
            "cite_spans": [
                {
                    "start": 297,
                    "end": 299,
                    "mention": "32",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 300,
                    "end": 302,
                    "mention": "33",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "IBD surgery in the context of the COVID-19 pandemic ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Before embarking upon the operating room, different aspects should be considered, such as\nthe risk of SARS-CoV-2 infection at your facility, expected length of stay, and possible\nsurgical complications and other clinical comorbidities that may add additional\nmorbidity/mortality. If surgical treatment is deemed necessary, informed consent should be\nobtained addressing the risk of SARS-CoV-2 infection. Ideally, surgical patients should be\ntested pre-operatively for COVID-19, although this strategy is not possible in our\ninstitution where just symptomatic patients are being tested.",
            "cite_spans": [],
            "section": "IBD surgery in the context of the COVID-19 pandemic ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "There is no precise advice regarding which IBD patients would most likely benefit from\nsurgery in this context since IBD societies around the world have not specifically\naddressed surgical care. Therefore, medical judgment remains essential.",
            "cite_spans": [],
            "section": "IBD surgery in the context of the COVID-19 pandemic ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "Our group considers patients with anorectal septic complications (i.e.\nperianal abscess due to Crohn's disease), acute peritonitis, bowel obstruction,\nsevere/toxic colitis (toxic megacolon), and gastrointestinal hemorrhage who fail\nconservative treatment are possible surgical candidates during the pandemic, but cases\nshould be analyzed on an individual basis. Advanced colorectal malignancy that may\nprogress to unresectable disease can also be considered for surgery. When available,\nminimally invasive strategies such as percutaneous drainage of an abscess may be a good\nstrategy.",
            "cite_spans": [],
            "section": "IBD surgery in the context of the COVID-19 pandemic ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "IBD in children often presents with more extensive and severe disease than adults.\nTherefore, SARS-CoV-2 infection with digestive symptoms is of particular concern in\npediatric IBD (PIBD) patients. As of April 3rd, 2020, eleven children (younger\nthan 19 years) have been reported to have SARS-CoV-2 infection by SECURE-IBD from a total\nof 275 patients. No cases were from Brazil. Only one patient was younger than 9 years; all\ncases were outpatients and no deaths were reported. Some questions arose: are PIBD\npatients at increased risk of SARS-CoV-2 infection? Is the infection in PIBD more severe\nthan in adults? Should treatment be delayed or discontinued during the infection?",
            "cite_spans": [],
            "section": "Considerations regarding the pediatric IBD population ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "A recent paper from the Pediatric IBD PORTO Group of ESPGHAN outlined key information\nabout children with IBD and SARS-CoV-2 infection and provided clear guidance on how to\nproceed 12. Chinese and Korean pediatric GI\nspecialists reported 272 cases in children with IBD and SARS-CoV-2 infection during the\npandemic while Europeans reported 8 PIBD patients (14-19 years) with COVID-19 from the\nPORTO-IBD group and SECURE-IBD database.",
            "cite_spans": [
                {
                    "start": 181,
                    "end": 183,
                    "mention": "12",
                    "ref_id": "BIBREF11"
                }
            ],
            "section": "Considerations regarding the pediatric IBD population ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The Chinese experience reported 917 children with confirmed COVID-19 infections, and none\nof them had the diagnosis of IBD. In Korea, from 8,413 children with confirmed COVID-19\ndiagnosis, 272 (3.2%) had IBD and almost all (99.3%) continued IBD treatment. Among 4.8%\nof children that postponed biological infusion, 23% experienced an IBD flare.",
            "cite_spans": [],
            "section": "Considerations regarding the pediatric IBD population ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "In Europe, from the total of eight patients, seven were from the Porto-IBD and one\nadolescent (17 years) was from the SECURE-IBD database. The majority had Crohn's disease\nand most patients were in deep remission or had a moderate disease activity index, and\nonly one had cardiovascular disease. Almost all patients had a confirmed diagnosis of\nCOVID-19 with mild symptoms of fever, cough, fatigue, and interestingly, none of the eight\npatients had diarrhea.",
            "cite_spans": [],
            "section": "Considerations regarding the pediatric IBD population ::: INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "This initial global experience may help many PIBD centers in the world implement actions\nduring the COVID-19 pandemic. Nevertheless, many questions about children and PIBD\nCOVID-19 infections remain unanswered. The main recommendations pertaining to treatment of\nPIBD during the COVID-19 pandemic are listed in Table\n3.",
            "cite_spans": [],
            "section": "Considerations regarding the pediatric IBD population ::: INTRODUCTION",
            "ref_spans": [
                {
                    "start": 311,
                    "end": 318,
                    "mention": "Table\n3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "In the current COVID-19 pandemic, the search for safety information and guidance is\ncritical. IBD patients have a potentially higher risk of complications of COVID-19 due to\nthe chronic illness itself, and mainly, the use of immunosuppressant treatments. Facing\nthese challenging circumstances, our group has adapted IBD care by resetting priorities,\nproviding appropriate information for patients, and assuring continuity of treatments.\nFinally, it is of paramount importance to remember that in developing countries, a\nsignificant part of the population lives in precarious conditions, with crowding, slum\ndwelling, and lack of basic sanitation, among other unique features, which deserve special\nattention from health authorities and effective adaptations. It turns out that, in this\nscenario, especially in the case of IBD patients, treatment individualization is mandatory,\nand the benefits and disadvantages should always be taken into account.",
            "cite_spans": [],
            "section": "CONCLUSION",
            "ref_spans": []
        },
        {
            "text": "Queiroz NSF was responsible for the study conceptualization, manuscript original drafting,\nediting and review. Barros LL, Azevedo MFC, Sobrado CW, Carlos AS and Milani LR were\nresponsible for manuscript drafting. Oba J was responsible for the study conceptualization,\ndata curation, formal analysis, funding acquisition, investigation, methodology, project\nadministration, resources planning, supervision and manuscript original drafting, editing\nand review. Sipahi AM and Dami\ufffdo AOMC were responsible for the manuscript editing and\nreview.",
            "cite_spans": [],
            "section": "AUTHOR CONTRIBUTIONS",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Recommendations for IBD patients according to their risk level.\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Measures to adapt IBD care during the pandemic.\n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Therapy-specific considerations for inflammatory bowel disease patients (UC=ulcerative\ncolitis; CD=Crohn\u2019s disease).\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "A Novel Coronavirus from Patients with Pneumonia in China,\n2019",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "(8)",
            "pages": "727-33",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001017"
                ]
            }
        },
        "BIBREF1": {
            "title": "COVID-19 epidemic: disease characteristics in children",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jiatong",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lanqin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wenjun",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25807"
                ]
            }
        },
        "BIBREF2": {
            "title": "Clinical features of patients infected with 2019 novel coronavirus in\nWuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "(10223)",
            "pages": "497-506",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30183-5"
                ]
            }
        },
        "BIBREF3": {
            "title": "Characteristics of and Important Lessons From the Coronavirus Disease 2019\n(COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center\nfor Disease Control and Prevention",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "McGoogan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.2648"
                ]
            }
        },
        "BIBREF4": {
            "title": "Epidemiological Characteristics of 2143 Pediatric Patients With 2019\nCoronavirus Disease in China",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Mo",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Qi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Pediatrics",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2020-0702"
                ]
            }
        },
        "BIBREF5": {
            "title": "Gastrointestinal symptoms of 95 cases with SARS-CoV-2\ninfection",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Gut",
            "volume": "",
            "issn": "",
            "pages": "gutjnl-2020-321013",
            "other_ids": {
                "DOI": [
                    "10.1136/gutjnl-2020-321013"
                ]
            }
        },
        "BIBREF6": {
            "title": "Implications of COVID-19 for patients with pre-existing digestive\ndiseases",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ghosh",
                    "suffix": ""
                },
                {
                    "first": "LR",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Gastroenterol Hepatol",
            "volume": "",
            "issn": "",
            "pages": "S2468-1253(20)30076-5",
            "other_ids": {
                "DOI": [
                    "10.1016/S2468-1253(20)30076-5"
                ]
            }
        },
        "BIBREF7": {
            "title": "Detection of SARS-CoV-2 in Different Types of Clinical\nSpecimens",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.3786"
                ]
            }
        },
        "BIBREF8": {
            "title": "Evidence for Gastrointestinal Infection of SARS-CoV-2",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Gastroenterology",
            "volume": "",
            "issn": "",
            "pages": "S0016-5085(20)30282-1",
            "other_ids": {
                "DOI": [
                    "10.1053/j.gastro.2020.02.055"
                ]
            }
        },
        "BIBREF9": {
            "title": "Do children need a longer time to shed SARS-CoV-2 in stool than\nadults?",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Gai",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Microbiol Immunol Infect",
            "volume": "",
            "issn": "",
            "pages": "S1684-1182(20)30070-0",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jmii.2020.03.010"
                ]
            }
        },
        "BIBREF10": {
            "title": "Management of IBD during the COVID-19 outbreak: resetting clinical\npriorities",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Danese",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cecconi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Spinelli",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Rev Gastroenterol Hepatol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41575-020-0294-8"
                ]
            }
        },
        "BIBREF11": {
            "title": "COVID-19 and Paediatric Inflammatory Bowel Diseases: Global Experience and\nProvisional Guidance (March 2020) from the Paediatric IBD Porto group of\nESPGHAN",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Turner",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Martin-de-Carpi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Aloi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Focht",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Pediatr Gastroenterol Nutr",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1097/MPG.0000000000002729"
                ]
            }
        },
        "BIBREF12": {
            "title": "Coronaviruses and immunosuppressed patients. The facts during the third\nepidemic",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "D'Antiga",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Liver Transpl",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/lt.25756"
                ]
            }
        },
        "BIBREF13": {
            "title": "Management of Patients with Crohn\u2019s Disease and Ulcerative Colitis\nDuring the COVID-19 Pandemic: Results of an International Meeting",
            "authors": [
                {
                    "first": "DT",
                    "middle": [],
                    "last": "Rubin",
                    "suffix": ""
                },
                {
                    "first": "MT",
                    "middle": [],
                    "last": "Abreu",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rai",
                    "suffix": ""
                },
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Siegel",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Gastroenterology",
            "volume": "",
            "issn": "",
            "pages": "S0016-5085(20)30465-0",
            "other_ids": {
                "DOI": [
                    "10.1053/j.gastro.2020.04.002"
                ]
            }
        },
        "BIBREF14": {
            "title": "Second European evidence-based consensus on the prevention, diagnosis and\nmanagement of opportunistic infections in inflammatory bowel disease",
            "authors": [
                {
                    "first": "JF",
                    "middle": [],
                    "last": "Rahier",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Magro",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Abreu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Armuzzi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ben-Horin",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Chowers",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "J Crohns Colitis",
            "volume": "8",
            "issn": "(6)",
            "pages": "443-68",
            "other_ids": {
                "DOI": [
                    "10.1016/j.crohns.2013.12.013"
                ]
            }
        },
        "BIBREF15": {
            "title": "Risk of Serious and Opportunistic Infections Associated With Treatment of\nInflammatory Bowel Diseases",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kirchgesner",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lemaitre",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Carrat",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zureik",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Carbonnel",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Dray-Spira",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Gastroenterology",
            "volume": "155",
            "issn": "(2)",
            "pages": "337-346.e10",
            "other_ids": {
                "DOI": [
                    "10.1053/j.gastro.2018.04.012"
                ]
            }
        },
        "BIBREF16": {
            "title": "Increased incidence of systemic serious viral infections in patients with\ninflammatory bowel disease associates with active disease and use of\nthiopurines",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wisniewski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kirchgesner",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Seksik",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Landman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bourrier",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Nion-Larmurier",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "United Eur Gastroenterol J",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1177/2050640619889763"
                ]
            }
        },
        "BIBREF17": {
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in\nChina",
            "authors": [
                {
                    "first": "WJ",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "ZY",
                    "middle": [],
                    "last": "Ni",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "WH",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "CQ",
                    "middle": [],
                    "last": "Ou",
                    "suffix": ""
                },
                {
                    "first": "JX",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF18": {
            "title": "COVID-19: faecal-oral transmission?",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hindson",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Rev Gastroenterol Hepatol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41575-020-0295-7"
                ]
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "British Society of Gastroenterology (BSG) advice for management of\ninflammatory bowel diseases during the COVID-19 pandemic",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Identifying and testing candidate genetic polymorphisms in the irritable\nbowel syndrome (IBS): association with TNFSF15 and TNF\u03b1",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Swan",
                    "suffix": ""
                },
                {
                    "first": "NP",
                    "middle": [],
                    "last": "Duroudier",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Campbell",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zaitoun",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hastings",
                    "suffix": ""
                },
                {
                    "first": "GE",
                    "middle": [],
                    "last": "Dukes",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Gut",
            "volume": "62",
            "issn": "(7)",
            "pages": "985-94",
            "other_ids": {
                "DOI": [
                    "10.1136/gutjnl-2011-301213"
                ]
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Nutritional deficiencies in inflammatory bowel disease: therapeutic\napproaches",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Massironi",
                    "suffix": ""
                },
                {
                    "first": "RE",
                    "middle": [],
                    "last": "Rossi",
                    "suffix": ""
                },
                {
                    "first": "FA",
                    "middle": [],
                    "last": "Cavalcoli",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Della Valle",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Fraquelli",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Conte",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Clin Nutr",
            "volume": "32",
            "issn": "(6)",
            "pages": "904-10",
            "other_ids": {
                "DOI": [
                    "10.1016/j.clnu.2013.03.020"
                ]
            }
        },
        "BIBREF23": {
            "title": "Hypoalbuminemia: Pathogenesis and Clinical Significance",
            "authors": [
                {
                    "first": "PB",
                    "middle": [],
                    "last": "Soeters",
                    "suffix": ""
                },
                {
                    "first": "RR",
                    "middle": [],
                    "last": "Wolfe",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shenkin",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "JPEN J Parenter Enteral Nutr",
            "volume": "43",
            "issn": "(2)",
            "pages": "181-93",
            "other_ids": {
                "DOI": [
                    "10.1002/jpen.1451"
                ]
            }
        },
        "BIBREF24": {
            "title": "Detectable Laboratory Abnormality Is Present up to 12 Months Prior to\nDiagnosis in Patients with Crohn's Disease",
            "authors": [
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Irwin",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ferguson",
                    "suffix": ""
                },
                {
                    "first": "LA",
                    "middle": [],
                    "last": "Simms",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hanigan",
                    "suffix": ""
                },
                {
                    "first": "JD",
                    "middle": [],
                    "last": "Doecke",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Langguth",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Dig Dis Sci",
            "volume": "64",
            "issn": "(2)",
            "pages": "503-17",
            "other_ids": {
                "DOI": [
                    "10.1007/s10620-018-5357-0"
                ]
            }
        },
        "BIBREF25": {
            "title": "Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease:\nthe NSQIP Surgical Cohort",
            "authors": [
                {
                    "first": "GC",
                    "middle": [],
                    "last": "Nguyen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "RY",
                    "middle": [],
                    "last": "Chong",
                    "suffix": ""
                },
                {
                    "first": "TD",
                    "middle": [],
                    "last": "Jackson",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Crohns Colitis",
            "volume": "13",
            "issn": "(11)",
            "pages": "1433-8",
            "other_ids": {
                "DOI": [
                    "10.1093/ecco-jcc/jjz083"
                ]
            }
        },
        "BIBREF26": {
            "title": "ECCO Guidelines on Therapeutics in Crohn's Disease: Medical\nTreatment",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Torres",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bonovas",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Doherty",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kucharzik",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Gisbert",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Raine",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Crohns Colitis",
            "volume": "14",
            "issn": "(1)",
            "pages": "4-22",
            "other_ids": {
                "DOI": [
                    "10.1093/ecco-jcc/jjz180"
                ]
            }
        },
        "BIBREF27": {
            "title": "Third European Evidence-based Consensus on Diagnosis and Management of\nUlcerative Colitis. Part 2: Current Management",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Harbord",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Eliakim",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Bettenworth",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Karmiris",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Katsanos",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Kopylov",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Crohns Colitis",
            "volume": "11",
            "issn": "(7)",
            "pages": "769-84",
            "other_ids": {
                "DOI": [
                    "10.1093/ecco-jcc/jjx009"
                ]
            }
        },
        "BIBREF28": {
            "title": "Potential interventions for novel coronavirus in China: A systematic\nreview",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "92",
            "issn": "(5)",
            "pages": "479-90",
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25707"
                ]
            }
        },
        "BIBREF29": {
            "title": "British Society of Gastroenterology consensus guidelines on the management\nof inflammatory bowel disease in adults",
            "authors": [
                {
                    "first": "CA",
                    "middle": [],
                    "last": "Lamb",
                    "suffix": ""
                },
                {
                    "first": "NA",
                    "middle": [],
                    "last": "Kennedy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Raine",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Hendy",
                    "suffix": ""
                },
                {
                    "first": "PJ",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "JK",
                    "middle": [],
                    "last": "Limdi",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Gut",
            "volume": "68",
            "issn": "(Suppl 3)",
            "pages": "s1-s106",
            "other_ids": {
                "DOI": [
                    "10.1136/gutjnl-2019-318484"
                ]
            }
        },
        "BIBREF30": {
            "title": "Clinical characteristics and outcomes of patients undergoing surgeries\nduring the incubation period of COVID-19 infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lei",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Mei",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "EClinicalMedicine",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.eclinm.2020.100331"
                ]
            }
        },
        "BIBREF31": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        }
    }
}